Clínica Baviera, S.A.

BME:CBAV Voorraadrapport

Marktkapitalisatie: €572.2m

Clínica Baviera Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Eduardo Baviera Sabater

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO30.2yrs
Eigendom CEO1.8%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur7.3yrs

Recente managementupdates

Recent updates

Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital

Oct 18
Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital

Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Sep 19
Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings

Jul 13
Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings

Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Mar 01
Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405

Nov 20
Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405

Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital

Jan 20
Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital

These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Sep 15
These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

Apr 12
Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Mar 21
Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 22
Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?

Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return

Jan 30
Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return

Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital

Jan 09
Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital

Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative

Dec 19
Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative

Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet

Nov 28
Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet

CEO

Eduardo Baviera Sabater (56 yo)

30.2yrs

Tenure

€200,000

Compensatie

Mr. Eduardo Baviera Sabater serves as the Chief Executive Officer of Clínica Baviera, S.A. and served as its Executive Chairman since February 12 2007 and also serves as its Managing Director. Mr. Baviera...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Eduardo Baviera Sabater
MD, CEO & Executive Director30.2yrs€200.00k1.81%
€ 10.4m
Isabel Aguilera Navarro
Independent Director3.8yrsgeen gegevensgeen gegevens
Bang Chen
Chairman7.3yrsgeen gegevensgeen gegevens
Shi Jun Wu
Director7.3yrsgeen gegevensgeen gegevens
Li Li
Director7.3yrsgeen gegevensgeen gegevens
Yongmei Zhang
Director7.3yrsgeen gegevensgeen gegevens

7.3yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CBAV wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).